Clinical Trial Update: Real-life Treatment Outcomes of Ravulizumab in PNH

View source ↗

Summary

This study reports real-world treatment outcomes of Ravulizumab in patients with paroxysmal nocturnal haemoglobinuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Haemoglobinuria

Drugs mentioned

• Ultomiris (ravulizumab) (ravulizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Paroxysmal Nocturnal Haemoglobinuria | Status: ACTIVE_NOT_RECRUITING